These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12852440)

  • 1. Modulation of tumor-selective vascular blood flow and extravasation by the stable prostaglandin 12 analogue beraprost sodium.
    Tanaka S; Akaike T; Wu J; Fang J; Sawa T; Ogawa M; Beppu T; Maeda H
    J Drug Target; 2003 Jan; 11(1):45-52. PubMed ID: 12852440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of low-dose Beraprost sodium, a stable prostaglandin I2 analogue, on reperfusion injury to rabbit lungs.
    Jiang XW; Kambara K; Gotoh N; Nishigaki K; Fujiwara H
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1669-75. PubMed ID: 9817723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulation of beraprost sodium in nanoparticles: analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertension.
    Ishihara T; Hayashi E; Yamamoto S; Kobayashi C; Tamura Y; Sawazaki R; Tamura F; Tahara K; Kasahara T; Ishihara T; Takenaga M; Fukuda K; Mizushima T
    J Control Release; 2015 Jan; 197():97-104. PubMed ID: 25449809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of progressive burn injury by a stable prostaglandin I2 analogue, beraprost sodium (Procylin): an experimental study in rats.
    Battal MN; Hata Y; Matsuka K; Ito O; Matsuda H; Yoshida Y; Kawazoe T
    Burns; 1996 Nov; 22(7):531-8. PubMed ID: 8909753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a prostaglandin I2 analogue, beraprost sodium, on burn-induced gastric mucosal injury in rats.
    Battal MN; Hata Y; Matsuka K; Ito O; Matsuda H; Yoshida Y; Kawazoe T; Nagao M
    Burns; 1997 May; 23(3):232-7. PubMed ID: 9232284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin I2 analog suppresses lung metastasis by recruiting pericytes in tumor angiogenesis.
    Minami Y; Sasaki T; Bochimoto H; Kawabe J; Endo S; Hira Y; Watanabe T; Okumura S; Hasebe N; Ohsaki Y
    Int J Oncol; 2015 Feb; 46(2):548-54. PubMed ID: 25434699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls.
    Nakamura H; Fang J; Maeda H
    Expert Opin Drug Deliv; 2015 Jan; 12(1):53-64. PubMed ID: 25425260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by beraprost sodium of thrombin-induced increase in endothelial macromolecular permeability.
    Imai-Sasaki R; Kainoh M; Ogawa Y; Ohmori E; Asai Y; Nakadate T
    Prostaglandins Leukot Essent Fatty Acids; 1995 Aug; 53(2):103-8. PubMed ID: 7480071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beraprost sodium, a stable prostacyclin analogue, elicits dilation of isolated porcine retinal arterioles: roles of eNOS and potassium channels.
    Ono S; Nagaoka T; Omae T; Tanano I; Kamiya T; Otani S; Ishibazawa A; Yoshida A
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(9):5752-9. PubMed ID: 25082887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research and development of beraprost sodium, a new stable PGI2 analogue].
    Nishio S; Nagase H; Kanou K; Aoki S; Kanbayashi Y
    Yakugaku Zasshi; 1997 Aug; 117(8):509-21. PubMed ID: 9306726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination of oral endothelin-A receptor antagonist and oral prostacyclin analogue is superior to each drug alone in ameliorating pulmonary hypertension in rats].
    Ueno M; Miyauchi T; Sakai S; Yamauchi-Kohno R; Goto K; Yamaguchi I
    J Cardiol; 2003 Jan; 41(1):45-6. PubMed ID: 12564116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of restenosis by beraprost sodium (a prostaglandin I2 analogue) in the atherosclerotic rabbit artery after angioplasty.
    Isogaya M; Yamada N; Koike H; Ueno Y; Kumagai H; Ochi Y; Okazaki S; Nishio S
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):947-52. PubMed ID: 7564340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.
    Fang J; Nakamura H; Maeda H
    Adv Drug Deliv Rev; 2011 Mar; 63(3):136-51. PubMed ID: 20441782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS.
    Fang J; Sawa T; Maeda H
    Adv Exp Med Biol; 2003; 519():29-49. PubMed ID: 12675206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of beraprost sodium and prostaglandin E1 on skin blood flow in diabetic rats and normal dogs.
    Ueno Y; Yamada N; Koike H; Nishio S
    Gen Pharmacol; 1996 Mar; 27(2):333-5. PubMed ID: 8919652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of beraprost sodium, a stable analogue of PGI2, and its mechanisms.
    Ueno Y; Koike H; Annoh S; Nishio S
    Prostaglandins; 1997 Apr; 53(4):279-89. PubMed ID: 9167214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
    Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beraprost sodium on renal function and inflammatory factors of rats with diabetic nephropathy.
    Guan J; Long L; Chen YQ; Yin Y; Li L; Zhang CX; Deng L; Tian LH
    Genet Mol Res; 2014 Jun; 13(2):4154-8. PubMed ID: 25036159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of diabetic nephropathy in OLETF rats by prostaglandin I(2) analog, beraprost sodium.
    Watanabe M; Nakashima H; Mochizuki S; Abe Y; Ishimura A; Ito K; Fukushima T; Miyake K; Ogahara S; Saito T
    Am J Nephrol; 2009; 30(1):1-11. PubMed ID: 19158439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute decrease of cardio-ankle vascular index with the administration of beraprost sodium.
    Takahashi M; Shiba T; Hirano K; Hitsumoto T; Shirai K
    J Atheroscler Thromb; 2012; 19(5):479-84. PubMed ID: 22659532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.